Singapore markets open in 3 hours 56 minutes

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7500-0.0700 (-8.54%)
At close: 04:00PM EST
0.7500 0.00 (0.00%)
After hours: 04:02PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
17,799
16,527
22,114
15,087
13,073
Cost of revenue
14,784
14,894
15,479
9,798
7,420
Gross profit
3,015
1,634
6,635
5,289
5,653
Operating expenses
Research development
10,737
8,281
10,376
18,794
7,527
Selling general and administrative
34,207
30,581
25,288
25,948
22,819
Total operating expenses
45,274
38,861
35,664
44,742
30,346
Operating income or loss
-42,259
-37,228
-29,029
-39,453
-24,693
Interest expense
163.064
159.628
123.258
157.765
231.291
Total other income/expenses net
-9,750
-12,001
-322.106
-10.517
-1,057
Income before tax
-52,202
-49,389
-29,298
-39,376
-25,878
Income tax expense
2.174
2.174
8.672
-369.34
-339.391
Income from continuing operations
-52,204
-49,391
-29,307
-39,007
-25,539
Net income
-54,913
-49,391
-29,307
-39,007
-25,539
Net income available to common shareholders
-54,913
-49,391
-29,307
-39,007
-25,539
Basic EPS
-
-
-0.55
-1.00
-0.90
Diluted EPS
-
-
-0.55
-1.00
-0.90
Basic average shares
-
-
53,264
39,085
28,349
Diluted average shares
-
-
53,264
39,085
28,349
EBITDA
-
-45,622
-26,230
-36,119
-22,584